Arrowhead Pharmaceuticals Inc (ARWR)
EBITDA Growth
-154.58%
TTM · Period ending:
ARWR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-154.58%period ending
Latest reported-154.58%period ending
ARWR TTM EBITDA YoY % (898.57% → -154.58%)
Year-over-year change
High-resolution chart · PNG
ARWR ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 36.6047% | |
| -121.4311% | |
| -121.6571% | |
| -120.7373% | |
| -128.2527% | |
| 707.1388% | |
| 898.5683% |